Hereditary Cancer Risk Variants Found in Significant Subset of Metastatic Breast Cancer Patients

Aug 30, 2019

|

NEW YORK – Investigators from Johns Hopkins University School of Medicine and the Vanderbilt Ingram Cancer Center have demonstrated that there is a potential benefit to doing widespread hereditary cancer risk testing in individuals with metastatic breast cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

Recent Headlines from
Precision Oncology News

The Scan

Pushback on Mosquito Paper

A new paper says an effort to introduce gene drives into mosquitos altered the genetic makeup of the local mosquitos, but the company behind the project says the paper is flawed.

DNA for Attorneys

Virginia's Department of Forensic Science is offering attorneys a course on DNA testing, the Virginian-Pilot reports.

Wheat Over Time

Researchers examine changes in the genomes of emmer wheat populations where the climate has warmed, the BBC reports.

Cell Presents Reptilian Model for Gene Editing, Melanoma Proteomics, More

In Cell this week: microinjection of CRISPR-Cas9 enables targeted mutations in Anolis, melanoma proteomic profiling, and more.

Featured White Papers

De Novo Genome Assembly with Illumina Sequencing and the NRGene DeNovoMAGIC Solution

Nextera DNA Flex Library Preparation for Soil Shotgun Metagenomics Analysis

A High-Performance Solution Combining CleanPlex OncoZoom Cancer Hotspot Panel and SOPHiA AI for Rapid Characterization of Somatic Mutations

Measuring DNA Concentration with Less Time and More Accuracy

Sep

25

Featured Webinar

Biomarker Evaluation for CAR T-Cell Therapy: Impact on Drug Development

CAR T-cell therapy is an innovative form of immunotherapy that is finding increasing use for the management of blood cancers.

Oct

01

Featured Webinar

Future-Proofing a Genomics Core: Considerations When Adopting New NGS Technologies

This webinar will provide an overview of the sequencing capabilities of the Tumor Profiling Unit at the Institute for Cancer Research in London, with a focus on the lab's strategy for bringing in new genomics technologies.

Oct

08

Featured Webinar

Integration of Single Cell and Spatially Resolved Methods for Understanding Neurodegeneration in ALS

This webinar will discuss a study that used spatial transcriptomics to gain insight into the molecular mechanisms of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease.

Oct

10

Featured Webinar

Laboratory Validation of a Kit-Based Liquid Biopsy NGS Assay

This webinar will provide an overview of how a pathology laboratory validated a 77-gene next-generation sequencing-based liquid biopsy assay.

Menu